Peripheral Arterial Disease Is Associated With Higher Rates of Hip Bone Loss and Increased Fracture Risk in Older Men

Background— Peripheral arterial disease (PAD) and osteoporosis are chronic illnesses that increase in prevalence with aging and certain metabolic disorders. The association between PAD, rates of bone loss, and fracture risk in older men is uncertain. Methods and Results— We sought to test the hypothesis that PAD is associated with higher rates of bone loss and increased fracture risk. We analyzed data from a prospective cohort study involving 6 US centers and 5781 men at least 65 years of age. We assessed ankle-brachial index and hip bone mineral density, followed up prospectively for changes in hip bone mineral density and fractures. PAD was defined as a baseline ankle-brachial index <0.9. Hip bone mineral density was measured with dual x-ray absorptiometry at baseline and again an average of 4.6 years later. Incident nonspine fractures were ascertained by self-report and confirmed with radiography reports during an average of 5.4 years of follow-up. At baseline, the prevalence of PAD was 6.2%. After adjustment for age, race, site, and baseline bone mineral density, the mean annualized rate of bone loss at the total hip was −0.66% per year (95% confidence interval −0.78 to −0.54) in men with PAD compared with −0.34% per year (95% confidence interval −0.36 to −0.31) in men without PAD (P<0.001). After further adjustment for multiple potential confounders, the difference was attenuated (−0.49% in men with PAD versus −0.35% in men without PAD) but remained significant (P=0.02). Findings were similar at hip subregions. Twelve percent of men with PAD and 7.9% of those without PAD experienced an incident nonspine fracture (hazard ratio adjusted for age, race, and site=1.47, 95% confidence interval 1.07 to 2.04); this association was not altered substantially by further adjustment for multiple confounders. Conclusions— In community-dwelling older men, PAD was associated with higher rates of hip bone loss and increased risk of nonspine fractures. Further research should examine the biological mechanisms underlying the association between reduced limb blood flow and fractures.

[1]  C. Ding,et al.  Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study. , 2008, The Journal of clinical endocrinology and metabolism.

[2]  S. Cummings,et al.  Renal function and rate of hip bone loss in older men: the Osteoporotic Fractures in Men Study , 2008, Osteoporosis International.

[3]  S. Cummings,et al.  Inflammatory Markers and Incident Fracture Risk in Older Men and Women: The Health Aging and Body Composition Study , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  M. Suarez‐Almazor,et al.  Process of Care and Outcomes in Patients with Peripheral Arterial Disease , 2007, Journal of General Internal Medicine.

[5]  J. Rumberger,et al.  Relationship between Vascular Calcification and Bone Mineral Density in the Old-Order Amish , 2007, Calcified Tissue International.

[6]  K. Matthews,et al.  The association of bone mineral density measures with incident cardiovascular disease in older adults , 2007, Osteoporosis International.

[7]  S. Cummings,et al.  Renal function and risk of hip and vertebral fractures in older women. , 2007, Archives of internal medicine.

[8]  S. Kiechl,et al.  High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study. , 2006, Archives of internal medicine.

[9]  K. Matthews,et al.  Volumetric BMD and Vascular Calcification in Middle‐Aged Women: The Study of Women's Health Across the Nation , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  J. Cauley,et al.  Volumetric and Areal Bone Mineral Density Measures Are Associated with Cardiovascular Disease in Older Men and Women: The Health, Aging, and Body Composition Study , 2006, Calcified Tissue International.

[11]  D. Towler,et al.  Molecular mechanisms of vascular calcification: lessons learned from the aorta. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[12]  Su‐Li Cheng,et al.  Osteogenic Regulation of Vascular Calcification , 2006, Annals of the New York Academy of Sciences.

[13]  John V. White,et al.  ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography , 2006, Circulation.

[14]  John V. White,et al.  ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography , 2006, Circulation.

[15]  E. Barrett-Connor,et al.  Differences in association of bone mineral density with coronary artery calcification in men and women: the Rancho Bernardo Study , 2005, Menopause.

[16]  P. Cawthon,et al.  Overview of recruitment for the osteoporotic fractures in men study (MrOS). , 2005, Contemporary clinical trials.

[17]  S. Cummings,et al.  Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men. , 2005, Contemporary clinical trials.

[18]  B. Davis,et al.  Diabetes mellitus, smoking, and the risk for asymptomatic peripheral arterial disease: whom should we screen? , 2005, The Journal of the American Board of Family Practice.

[19]  J. Woo,et al.  Bone mineral density and the risk of peripheral arterial disease in men and women: results from Mr. and Ms Os, Hong Kong , 2005, Osteoporosis International.

[20]  S. Bandinelli,et al.  Patterns of inflammation associated with peripheral arterial disease: the InCHIANTI study. , 2005, American heart journal.

[21]  J. Pérez-Castrillón,et al.  Homocysteine as a predictive factor for hip fracture in older persons. , 2004, The New England journal of medicine.

[22]  J. Sayre,et al.  Aortic calcification and the risk of osteoporosis and fractures. , 2004, The Journal of clinical endocrinology and metabolism.

[23]  A. Hofman,et al.  Homocysteine levels and the risk of osteoporotic fracture. , 2004, The New England journal of medicine.

[24]  D. Towler,et al.  Osteogenic regulation of vascular calcification: an early perspective. , 2004, American journal of physiology. Endocrinology and metabolism.

[25]  P. Pennisi,et al.  Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. , 2004, Osteoporosis International.

[26]  Richard B Devereux,et al.  Relationship of High and Low Ankle Brachial Index to All-Cause and Cardiovascular Disease Mortality: The Strong Heart Study , 2004, Circulation.

[27]  John J. Shin,et al.  Osteoporosis and cardiovascular disease , 2004, Endocrine.

[28]  M. Fornage,et al.  D-Dimer, Inflammatory Markers, and Lower Extremity Functioning in Patients With and Without Peripheral Arterial Disease , 2003, Circulation.

[29]  M. Suarez‐Almazor,et al.  The prevalence of peripheral arterial disease in a racially diverse population. , 2003, Archives of internal medicine.

[30]  C. Christiansen,et al.  Low Bone Mineral Density in the Hip as a Marker of Advanced Atherosclerosis in Elderly Women , 2003, Calcified Tissue International.

[31]  S. Cummings,et al.  Clinical use of bone densitometry: scientific review. , 2002, JAMA.

[32]  G. Ostir,et al.  Diabetes mellitus as a risk factor for hip fracture in mexican american older adults. , 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.

[33]  A. Hofman,et al.  Bone Mineral Density and the Risk of Peripheral Arterial Disease: The Rotterdam Study , 2002, Calcified Tissue International.

[34]  W. Henderson,et al.  Lower Extremity Nontraumatic Amputation Among Veterans With Peripheral Arterial Disease: Is Race an Independent Factor? , 2002, Medical care.

[35]  K. Johansen,et al.  Lower-extremity peripheral arterial disease among patients with end-stage renal disease. , 2001, Journal of the American Society of Nephrology : JASN.

[36]  W. Hiatt,et al.  Medical treatment of peripheral arterial disease and claudication. , 2001, The New England journal of medicine.

[37]  D. Kiel,et al.  Bone loss and the progression of abdominal aortic calcification over a 25 year period: The Framingham heart study , 2001, Calcified Tissue International.

[38]  A. Hofman,et al.  Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[39]  T. Greene,et al.  Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. , 2000, Kidney international.

[40]  E. Barengolts,et al.  Osteoporosis and Coronary Atherosclerosis in Asymptomatic Postmenopausal Women , 1998, Calcified Tissue International.

[41]  P. Ridker,et al.  Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. , 1998, Circulation.

[42]  L. Kuller,et al.  Bone Mineral Density and Blood Flow to the Lower Extremities: The Study of Osteoporotic Fractures , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[43]  A. Jette,et al.  The Physical Activity Scale for the Elderly (PASE): development and evaluation. , 1993, Journal of clinical epidemiology.

[44]  F. Fowkes,et al.  The measurement of atherosclerotic peripheral arterial disease in epidemiological surveys. , 1988, International journal of epidemiology.

[45]  H. Imura,et al.  Diabetic osteopenia and circulating levels of vitamin D metabolites in type 2 (noninsulin-dependent) diabetes. , 1985, Metabolism: clinical and experimental.

[46]  C. Abraira,et al.  Elevated Leg Systolic Pressures and Arterial Calcification in Diabetic Occlusive Vascular Disease , 1981, Diabetes Care.

[47]  L. Avioli,et al.  Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes. , 1976, The New England journal of medicine.

[48]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[49]  H Boccalon,et al.  Bone mineral decrease in the leg with unilateral chronic occlusive arterial disease. , 2003, Clinical and experimental rheumatology.